EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Recommendations to address key recruitment challenges of Alzheimer's disease clinical trials

Jessica B Langbaum, Julie Zissimopoulos, Rhoda Au, Niranjan Bose, Chris J Edgar, Evan Ehrenberg, Howard Fillit, Carl V Hill, Lynne Hughes, Michael Irizarry, Sarah Kremen, Darius Lakdawalla und 12 weitere

Alzheimer's & Dementia · 2023-02 · 19 (2) · 696-707

DOI: 10.1002/alz.12737 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Alzheimer's & Dementia, online erschienen am 10.08.2022. Verfasst von Jessica B Langbaum und 23 weiteren Autor:innen. Beteiligte Einrichtung: Banner Alzheimer's Institute, Phoenix, Arizona, USA. Hauptthemen laut MEDLINE: Alzheimer Disease. Die Arbeit wurde bisher 121-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, FDA HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Clinical trials for Alzheimer's disease (AD) are slower to enroll study participants, take longer to complete, and are more expensive than trials in most other therapeutic areas. The recruitment and retention of a large number of qualified, diverse volunteers to participate in clinical research studies remain among the key barriers to the successful completion of AD clinical trials. An advisory panel of experts from academia, patient‐advocacy organizations, philanthropy, non‐profit, government, and industry convened in 2020 to assess the critical challenges facing recruitment in Alzheimer's clinical trials and develop a set of recommendations to overcome them. This paper briefly reviews existing challenges in AD clinical research and discusses the feasibility and implications of the panel's recommendations for actionable and inclusive solutions to accelerate the development of novel therapies for AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseHumansPatient Selection

Stichwörter der Autor:innen

Alzheimer's diseaseclinical trialsdiversity in clinical trialsrecruitmentretentiontrial participation

Autor:innen und Institutionen

  • Banner Alzheimer's Institute, Phoenix, Arizona, USA.
  • Sol Price School of Public Policy and Leonard D. Schaeffer Center for Health Policy and Economics, University of Southern California, Los Angeles, California, USA.
  • Departments of Anatomy & Neurobiology, Neurology and Epidemiology, Boston University Schools of Medicine and Public Health, Boston, Massachusetts, USA.
  • Gates Ventures, Kirkland, Washington, USA.
  • Cogstate Ltd, Reading, UK.
  • Clara Health, San Francisco, California, USA.

Förderung

  • NIA NIH HHS
  • FDA HHS

Zitieren

APA

Langbaum, J. B., Zissimopoulos, J., Au, R., Bose, N., Edgar, C. J., Ehrenberg, E., Fillit, H., Hill, C. V., Hughes, L., Irizarry, M., Kremen, S., Lakdawalla, D., Lynn, N., Malzbender, K., Maruyama, T., Massett, H. A., Patel, D., Peneva, D., Reiman, E. M., …, & Aisen, P. S. (2023). Recommendations to address key recruitment challenges of Alzheimer's disease clinical trials. Alzheimer's & Dementia, 19(2), 696-707. https://doi.org/10.1002/alz.12737

Vancouver

Langbaum JB, Zissimopoulos J, Au R, Bose N, Edgar CJ, Ehrenberg E, et al. Recommendations to address key recruitment challenges of Alzheimer's disease clinical trials. Alzheimer's & Dementia. 2023;19(2):696-707. doi:10.1002/alz.12737

BibTeX
@article{Langbaum2023,
  author = {Langbaum, Jessica B and Zissimopoulos, Julie and Au, Rhoda and Bose, Niranjan and Edgar, Chris J and Ehrenberg, Evan and Fillit, Howard and Hill, Carl V and Hughes, Lynne and Irizarry, Michael and Kremen, Sarah and Lakdawalla, Darius and Lynn, Nancy and Malzbender, Kristina and Maruyama, Tetsuyuki and Massett, Holly A and Patel, Deep and Peneva, Desi and Reiman, Eric M and Romero, Klaus and Routledge, Carol and Weiner, Michael W and Weninger, Stacie and Aisen, Paul S},
  title = {Recommendations to address key recruitment challenges of Alzheimer's disease clinical trials},
  journal = {Alzheimer's & Dementia},
  year = {2023},
  volume = {19},
  number = {2},
  pages = {696--707},
  doi = {10.1002/alz.12737}
}
Kostenlos starten →